Information for activists, patients, health workers & researchers working to end tuberculosis
Website of the Global Tuberculosis Community Advisory Board
By PharmaTimes Published: June 2, 2013, 6:15 p.m.· Tags: None
GlaxoSmithKline has purchased the Swiss-based vaccine technology company Okairos for 250 million euros in a deal that will bolster the firm’s biologics division.
Read More →
Page 1 of 1 · Total posts: 1
